EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Co-Assembled Nanoparticles Comprising Sorafenib and Hederagenin Derivative for Enhanced Anti-Hepatic Fibrosis Activity

Mingjun Lu, Ziqi Dai, Yixuan Lin, Changsheng Sun, Shuo Li, Zhuoqian Guo, Yongji Liu, Xiaobi Liu, Shanlan Li, Runping Liu, Bing Xu, Haimin Lei

International Journal of Nanomedicine · 2025-07 · Volume 20 · 9135-9153

DOI: 10.2147/ijn.s512005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2025-07. Verfasst von Mingjun Lu und 11 weiteren Autor:innen. Beteiligte Einrichtung: School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, 100102, People's Republic of China. Hauptthemen laut MEDLINE: Sorafenib, Nanoparticles, Liver Cirrhosis, Oleanolic Acid. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SorafenibNanoparticlesLiver CirrhosisOleanolic AcidAnimalsHumansMiceHepatocytesSignal TransductionMaleLiverHepatic Stellate Cells

Stichwörter der Autor:innen

STING pathwayco-assemblyhederageninliver fibrosissorafenib

Substanzen

SorafenibOleanolic Acid

Autor:innen und Institutionen

  • School of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing, 100102, People's Republic of China.

Zitieren

APA

Lu, M., Dai, Z., Lin, Y., Sun, C., Li, S., Guo, Z., Liu, Y., Liu, X., Li, S., Liu, R., Xu, B., & Lei, H. (2025). Co-Assembled Nanoparticles Comprising Sorafenib and Hederagenin Derivative for Enhanced Anti-Hepatic Fibrosis Activity. International Journal of Nanomedicine, Volume 20, 9135-9153. https://doi.org/10.2147/ijn.s512005

Vancouver

Lu M, Dai Z, Lin Y, Sun C, Li S, Guo Z, et al. Co-Assembled Nanoparticles Comprising Sorafenib and Hederagenin Derivative for Enhanced Anti-Hepatic Fibrosis Activity. International Journal of Nanomedicine. 2025;Volume 20:9135-9153. doi:10.2147/ijn.s512005

BibTeX
@article{Lu2025,
  author = {Lu, Mingjun and Dai, Ziqi and Lin, Yixuan and Sun, Changsheng and Li, Shuo and Guo, Zhuoqian and Liu, Yongji and Liu, Xiaobi and Li, Shanlan and Liu, Runping and Xu, Bing and Lei, Haimin},
  title = {Co-Assembled Nanoparticles Comprising Sorafenib and Hederagenin Derivative for Enhanced Anti-Hepatic Fibrosis Activity},
  journal = {International Journal of Nanomedicine},
  year = {2025},
  volume = {Volume 20},
  pages = {9135--9153},
  doi = {10.2147/ijn.s512005}
}
Kostenlos starten →